Literature DB >> 11584293

Recombineering: a powerful new tool for mouse functional genomics.

N G Copeland, N A Jenkins, D L Court.   

Abstract

Highly efficient phage-based Escherichia coli homologous recombination systems have recently been developed that enable genomic DNA in bacterial artificial chromosomes to be modified and subcloned, without the need for restriction enzymes or DNA ligases. This new form of chromosome engineering, termed recombinogenic engineering or recombineering, is efficient and greatly decreases the time it takes to create transgenic mouse models by traditional means. Recombineering also facilitates many kinds of genomic experiment that have otherwise been difficult to carry out, and should enhance functional genomic studies by providing better mouse models and a more refined genetic analysis of the mouse genome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584293     DOI: 10.1038/35093556

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  312 in total

Review 1.  Disentangling the MYC web.

Authors:  David Levens
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 2.  Gene targeting in the mouse: advances in introduction of transgenes into the genome by homologous recombination.

Authors:  Ravi P Misra; Stephen A Duncan
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

3.  Neurogenin 2 regulates progenitor cell-cycle progression and Purkinje cell dendritogenesis in cerebellar development.

Authors:  Marta Florio; Ketty Leto; Luca Muzio; Andrea Tinterri; Aurora Badaloni; Laura Croci; Paola Zordan; Valeria Barili; Ilaria Albieri; François Guillemot; Ferdinando Rossi; G Giacomo Consalez
Journal:  Development       Date:  2012-07       Impact factor: 6.868

4.  Development of a bacterial artificial chromosome (BAC) recombineering procedure using galK-untranslated region (UTR) for the mutation of diploid genes.

Authors:  Gan Dai; Seongman Kim; Dennis J O'Callaghan; Seong K Kim
Journal:  J Virol Methods       Date:  2012-03-08       Impact factor: 2.014

5.  Recombineering with overlapping single-stranded DNA oligonucleotides: testing a recombination intermediate.

Authors:  Daiguan Yu; James A Sawitzke; Hilary Ellis; Donald L Court
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

6.  Combination of overlapping bacterial artificial chromosomes by a two-step recombinogenic engineering method.

Authors:  Xin-Mei Zhang; Jian-Dong Huang
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

7.  A simple two-step, 'hit and fix' method to generate subtle mutations in BACs using short denatured PCR fragments.

Authors:  Yongping Yang; Shyam K Sharan
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

8.  Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.

Authors:  Mel Campbell; Pei-Ching Chang; Steve Huerta; Chie Izumiya; Ryan Davis; Clifford G Tepper; Kevin Y Kim; Bogdan Shevchenko; Don-Hong Wang; Jae U Jung; Paul A Luciw; Hsing-Jien Kung; Yoshihiro Izumiya
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

9.  Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting.

Authors:  Jun Fu; Xiaoying Bian; Shengbaio Hu; Hailong Wang; Fan Huang; Philipp M Seibert; Alberto Plaza; Liqiu Xia; Rolf Müller; A Francis Stewart; Youming Zhang
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

10.  IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Authors:  Deborah L Hodge; Cyril Berthet; Vincenzo Coppola; Wolfgang Kastenmüller; Matthew D Buschman; Paul M Schaughency; Hidekazu Shirota; Anthony J Scarzello; Jeff J Subleski; Miriam R Anver; John R Ortaldo; Fanching Lin; Della A Reynolds; Michael E Sanford; Philipp Kaldis; Lino Tessarollo; Dennis M Klinman; Howard A Young
Journal:  J Autoimmun       Date:  2014-02-28       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.